2026

• 03Series C funding
• 03MB7 material patent application (KIPO)

2025

• 12MB4 PCT material patent application (KIPO)
• 10Joint Development & License-out Agreement with Celltrion
• 08Celltrion, mustbio selected for open innovation
• 07Research project (MB4) selected for the APEX
• 04MB4, Research grant awarded from Korea Drug Development Fund (KDDF)
• 04Poster Presentation at AACR

2024

• 12MB4 material patent application (KIPO)
• 12Selected for the JLABS Korea Program
• 11MB5029, Research grant awarded from Korea Drug Development Fund (KDDF)
• 04MB5029 material patent registration (KIPO)
• 04Poster Presentation at AACR

2023

• 08MB5029 PCT material patent application
• 04Poster Presentation at AACR
• 03Series B-2 funding

2022

• 11Series B-1 funding
• 05Multi-specific Ab platform patent registration (KIPO)
• 05MB2, Research grant awarded from Korea Drug Development Fund (KDDF)

2021

• 11MB1, Research grant awarded from Korea Drug Development Fund (KDDF)
• 08Establishment of Research Center
• 05Series A funding
• 03Acquisition of multi-specific Ab platform (Ahngook)
• 02Establishment